[Effect of intravenous injection of synthetic TRH in hypophyseal pathology].
D000236:Adenoma / Q000175:diagnosis; D000238:Adenoma, Chromophobe / Q000175:diagnosis; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D000368:Aged; D001099:Arachnoid; D003397:Craniopharyngioma / Q000175:diagnosis; D005260:Female; D005910:Glioma / Q000175:diagnosis; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007018:Hypopituitarism / Q000175:diagnosis*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D008579:Meningioma / Q000175:diagnosis; D008875:Middle Aged; D010901:Pituitary Function Tests; D010911:Pituitary Neoplasms / Q000175:diagnosis*; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000097:blood
D013973:Thyrotropin-Releasing Hormone; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone
Effets de l'injection I.V. de TRH synthetique en pathologie hypophysaire.